These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 307737

  • 41. Nuclear deposits of immunoglobulins in skin of patients with systemic lupus erythematosus.
    Shu S, Provost T, Croxdale MB, Reichlin M, Beutner EH.
    Clin Exp Immunol; 1977 Feb; 27(2):238-44. PubMed ID: 300310
    [Abstract] [Full Text] [Related]

  • 42. High serum levels of antibodies against the recombinant 70 kDa ribonucleoprotein are useful for diagnosing mixed connective tissue disease.
    Salmhofer W, Hermann J, Joch M, Kerl H, Graninger W.
    J Eur Acad Dermatol Venereol; 2007 Sep; 21(8):1047-53. PubMed ID: 17714123
    [Abstract] [Full Text] [Related]

  • 43. [Clinical usefulness of determining the antibodies to soluble nuclear antigens in various collagen diseases].
    Dziankowska-Bartkowiak B, Lutowiecka-Wranicz A, Sysa-Jedrzejowska A, Torzecka D, Waszczykowska E.
    Przegl Dermatol; 1990 Sep; 77(5):332-5. PubMed ID: 2125351
    [Abstract] [Full Text] [Related]

  • 44. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases.
    Braun A, Sis J, Max R, Mueller K, Fiehn C, Zeier M, Andrassy K.
    Scand J Rheumatol; 2007 Sep; 36(4):291-8. PubMed ID: 17763207
    [Abstract] [Full Text] [Related]

  • 45. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
    Amoura Z, Koutouzov S, Chabre H, Cacoub P, Amoura I, Musset L, Bach JF, Piette JC.
    Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
    [Abstract] [Full Text] [Related]

  • 46. Assays for Sm and RNP antibodies: pitfalls and technical considerations.
    Molden DP, Suzuki H, Nakamura RM.
    Diagn Immunol; 1985 Jan; 3(1):24-8. PubMed ID: 3922661
    [Abstract] [Full Text] [Related]

  • 47. The clinical significance of antinuclear antibodies in connective tissue disease.
    Pahor A, Krajnc I, Gorenjak M, Holc I.
    Wien Klin Wochenschr; 1998 May 08; 110(9):338-41. PubMed ID: 9629626
    [Abstract] [Full Text] [Related]

  • 48. [Progress in laboratory tests of connective tissue diseases].
    Yamane K, Kato S, Sakauchi M.
    Rinsho Byori; 1989 Dec 08; 37(12):1311-6. PubMed ID: 2614963
    [Abstract] [Full Text] [Related]

  • 49. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse.
    Amigues JM, Cantagrel A, Abbal M, Mazieres B.
    J Rheumatol; 1996 Dec 08; 23(12):2055-62. PubMed ID: 8970041
    [Abstract] [Full Text] [Related]

  • 50. [Juvenile Sharp syndrome (mixed connective tissue disease)].
    Rosenthal M.
    Helv Paediatr Acta; 1978 Aug 08; 33(3):251-8. PubMed ID: 309464
    [Abstract] [Full Text] [Related]

  • 51. [Significance of antinuclear antibodies in the diagnosis of connective tissue diseases].
    Bambara LM, Biasi D, Caramaschi P, Codella O, Corrocher R, Serpelloni G, De Sandre G.
    Recenti Prog Med; 1985 Feb 08; 76(2):102-9. PubMed ID: 3887516
    [No Abstract] [Full Text] [Related]

  • 52. Clinical significance of anti-RNP and anti-Sm autoantibodies as determined by immunoblotting and immunoprecipitation in sera from patients with connective tissue diseases.
    Combe B, Rucheton M, Graafland H, Lussiez V, Brunel C, Sany J.
    Clin Exp Immunol; 1989 Jan 08; 75(1):18-24. PubMed ID: 2702772
    [Abstract] [Full Text] [Related]

  • 53. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D, Vogt P, Wu X, Rose L, Tyndall A, Hasler P.
    Z Rheumatol; 2002 Oct 08; 61(5):534-44. PubMed ID: 12399881
    [Abstract] [Full Text] [Related]

  • 54. Serological and clinical characterization of anti-dsDNA and anti-PM/Scl double-positive patients.
    Mahler M, Greidinger EL, Szmyrka M, Kromminga A, Fritzler MJ.
    Ann N Y Acad Sci; 2007 Aug 08; 1109():311-21. PubMed ID: 17785320
    [Abstract] [Full Text] [Related]

  • 55. [Antibodies to extractable nuclear antigen polypeptides: detection and its clinical significance].
    Xu YH.
    Zhonghua Yi Xue Za Zhi; 1992 Sep 08; 72(9):541-3, 573. PubMed ID: 1338517
    [Abstract] [Full Text] [Related]

  • 56. Clinical significance of antinuclear antibodies in systemic lupus erythematosus.
    Liu HW, Chi CY, Lin SF, Tsai JH, Chen CY.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1981 Sep 08; 14(3):135-45. PubMed ID: 7026188
    [Abstract] [Full Text] [Related]

  • 57. [Clinical features and laboratory findings in children with both anti-dsDNA and anti-U1-RNP antibody].
    Miyamae T, Ito S, Machida H, Ozawa R, Higuchi R, Nakajima S, Imagawa T, Nakamura T, Mori M, Aihara Y, Ohshige K, Yokota S.
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct 08; 31(5):405-14. PubMed ID: 18974625
    [Abstract] [Full Text] [Related]

  • 58. Mixed connective tissue disease in childhood. A clinical and serologic survey.
    Singsen BH, Bernstein BH, Kornreich HK, King KK, Hanson V, Tan EM.
    J Pediatr; 1977 Jun 08; 90(6):893-900. PubMed ID: 300795
    [Abstract] [Full Text] [Related]

  • 59. [Anti-nuclear antibodies in collagen diseases].
    Gintz B, Phelip X, Micouin C, Cabanel G.
    Sem Hop; 1975 Feb 20; 51(9):573-80. PubMed ID: 169588
    [Abstract] [Full Text] [Related]

  • 60. Clinical significance of antibodies to ribonucleoprotein.
    Cohen ML, Dawkins B, Dawkins RL, Owen ET.
    Ann Rheum Dis; 1979 Feb 20; 38(1):74-8. PubMed ID: 312058
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.